Association between vitamin D receptor, CCR5, TNF-α and TNF-β gene polymorphisms and HBV infection and severity of liver disease

Journal of Hepatology

Volumn 44, Issue 5, 2006, Pages 856-863

  Suneetha, Pothakamuri Venkata ^a   Sarin, Shiv Kumar ^a   Goyal, Ankur ^a   Kumar, Gollapudi Tharun ^a   Shukla, Deepak Kumar ^b   Hissar, Syed ^a  

^a G B PANT HOSPITAL   (India)

^b INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

Author keywords

CCR5; HBV; Single nucleotide polymorphism; VDR

Indexed keywords

CHEMOKINE RECEPTOR CCR5; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D RECEPTOR;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE PREDISPOSITION; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; GENE LINKAGE DISEQUILIBRIUM; HAPLOTYPE; HEPATITIS B; HETEROZYGOSITY; HUMAN; IMMUNOGENICITY; LIVER DISEASE; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PARAMETER; PRIORITY JOURNAL; SCORING SYSTEM; VIRUS INFECTION; VIRUS LOAD;

ADULT; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HEPATITIS B, CHRONIC; HETEROZYGOTE; HUMANS; LINKAGE DISEQUILIBRIUM; LYMPHOTOXIN-ALPHA; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CALCITRIOL; RECEPTORS, CCR5; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA; VIRAL LOAD;

EID: 33645770029     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2006.01.028     Document Type: Article

References (40)

1. Beasley R.P., Hwang L.Y., Lin C.C., and Chien C.S. Hepaocellular carcinoma and hepatitis B virus: a prospective study of 22707 men in Taiwan. Lancet 2 (1981) 1129-1133
2. Thursz M.R., Kwiatkowski D., Allsopp C.E.M., Greenwood B.M., Thomas H.C., and Hill A.V.S. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med 332 (1995) 1065-1069
3. Gurlek A., Peettelkow R., and Kumar R. Modulation of growth factor/cytokine synthesis and signaling by 1,25-dihydroxyvitamin D3: implications in cell growth and differentiation. Endocrine Rev 23 (2002) 763-786
4. Weitssman G.E., Ravid A., Liberman U.A., and Koren R. Vitamin D enhances caspase dependent and independent TNF-induced breast cancer cell death: the role of reactive oxygen species. Ann NY Acad Sci 1010 (2003) 437-440
5. Adams L.S., and Teegaarden D. 1,25-Dihydroxycholcaalciferol inhibits apoptosis in C3H10T1/2 murine fibroblast cells through activation of nuclear factor kappa B. J Nutr 134 (2003) 2948-2952
6. Abu-Amer Y., and Bar-Shavit Z. Regulation of TNF-_release from bone marrow-derived macrophages by vitamin D. J Cell Biochem 55 (1994) 435-444
7. Farquharson C., Law A.S., Seawright E., Burt D.W., and Whitehead C.C. The expression of transforming growth factor-β by cultured chick growth plate chondrocytes: differential regulation by 1,25-dihydroxyvitamin D3. J Endocrinol 149 (1996) 277-285
8. Cantorna M.T., Woodward W.D., Hayes C.E., and DeLuca H.F. 1,25-Dihydroxy vitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-β and IL-4. J Immunol 160 (1998) 5314-5319
9. Staeva-Vieira T.P., and Freedman L.P. 1,25-Dihydroxyvitamin D3 inhibits IFN and IL-4 levels during in vitro polarization of primary murine CD4 T cells. J Immunol 168 (2002) 1181-1189
10. Penna G., and Adorini L. 1,25-Dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 164 (2000) 2405-2411
11. Fukuoka M., Ogino Y., Sato H., Ohta T., Komoriya K., Nishioka K., et al. RANTES expression in psoriatic skin, and regulation of RANTES and IL-8 production in cultured epidermal keratinocytes by active vitamin D3 (tacalcitol). Br J Dermatol 138 (1998) 63-70
12. Bellamy R., Ruwende C., Corrah T., McAdam K.P.W.J., Thursz M., Whittle H.C., et al. Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J Infect Dis 179 (1999) 721724
13. Morrison N.A., Yeoman R., Kelly P.J., and Eisman J.A. Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin. Proc Natl Acad Sci USA 89 (1992) 6665-6669
14. Huang Y., Paxton W.A., Wolinsky S.M., Neumann A.U., Zhang L., He T., et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 2 (1996) 1240-1243
15. Woitas R.P., Ahlenstiel G., Iwan A., Rockstroh J.K., Brackmann H.H., Kupfer B., et al. Frequency of the HIV-protective CC chemokine receptor 5 Δ32/Δ32 genotype is increased in hepatitis C. Gastroenterology 122 (2002) 1721-1728
16. Kowdley K.V. TNF-α in chronic hepatitis C: the smoking gun?. Am J Gastroenterol 94 (1999) 1132-1135
17. Zyllberberg H., Rimaniol A.C., Pol S., Masson A., De Groote D., Berthelot P., et al. Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity. J Hepatol 30 (1999) 185-191
18. Goodman Z.D., and Ishak K.G. Histopathology of hepatitis C virus infection. Semin Liver Dis 15 (1995) 70-81
19. Lahiri D.K., Bye S., Nurnberger Jr. J.I., Hodes M.E., and Crisp M. A non-organic and non-enzymatic extraction method gives higher yields of genomic DNA from whole-blood samples than do nine other methods tested. J Biochem Biophys Methods 25 (1992) 193-205
20. Peltekova V., Cole D.E.C., Hawker G., Pavlova A.G., and Rubin L.A. Improved method for direct haplotyping at the vitamin D3 receptor locus. Clin Biochem 31 (1998) 191-194
21. Barber Y., Rubio C., Fernandez E., Rubio M., and Fibla J. Host genetic background at CCR5 chemokine receptor and vitamin D receptor loci and human immunodeficiency virus (HIV) type 1 disease progression among HIV-seropositive injection drug users. J Infect Dis 184 (2001) 1279-1288
22. Cabrera M., Shaw M.A., Sharples C., Williams H., Castes M., Convit J., et al. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med 182 (1995) 1259-1264
23. Zhang P., Wu J., Li Y., and Yang X. Association of polymorphisms of interleukin-18 gene promoter region with chronic hepatitis B in Chinese Han population. World J Gastroenterol 11 (2005) 1594-1598 p. 1594-8
24. Aranda A., and Pascual A. Nucleaar hormone receptors and gene expression. Physiol Rev 81 (2001) 1269-1304
25. Suzuki T., Sano Y., Sotozono C., and Kinoshita S. Regulatory effects of 1a,25-dihydroxyvitamin D3 on cytokine production by human corneal epithelial cells. Curr Eye Res 20 (2000) 127-130
26. Vogel A., Strassburg C.P., and Manns M.P. Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis. Hepatology 35 (2002) 126-131
27. McDermott M.F., Ramachandran A., Ogunkolade B.W., Aganna E., Curtis D., Boucher B.J., et al. Allelic variation in the vitamin D receptor influences susceptibility to IDDM in Indian Asians. Diabetologia 40 (1997) 971-975
28. Roy S., Frodsham A., Saha B., Hazra S.K., Mascie-Taylor C.G., and Hill A.V. Association of vitamin D receptor genotype with leprosy type. J Infect Dis 179 (1999) 187-191
29. Simmons J.D., Mullighan C., Welsh K.I., and Jewell D.P. Vitamin D receptor gene polymorphism: association with Crohn's disease susceptibility. Gut 47 (2000) 211-214
30. Curran J.E., Vaughan T., Lea R.A., Weinstein S.R., Morrison N.A., and Griffiths L.R. Association of A vitamin D receptor polymorphism with sporadic breast cancer development. Int J Cancer 83 (1999) 723-726
31. Yokoyama K., Shigematsu T., Tsukada T., Ogura Y., Takemoto F., Hara S., et al. Apa I polymorphism in the vitamin D receptor gene may affect the parathyroid response in Japanese with end-stage renal disease. Kidney Int 53 (1998) 454-458
32. Park B.Y., Park J.S., Lee D.Y., Youn J.I., and Kim I.G. Vitamin D receptor polymorphism is associated with psoriasis. J Invest Dermatol 112 (1999) 113-116
33. Lichterfeld M., Leifeld L., Nischalke H.D., Rockstroh J.K., Hess L., Sauerbruch T., et al. Reduced CC chemokine receptor (CCR) 1 and CCR5 surface expression on peripheral blood T lymphocytes from patients with chronic hepatitis C infection. J Infect Dis 185 (2002) 1803-1807
34. Ahlenstiel G., Berg T., Woitas R.P., Grunhage F., Iwan A., Hess L., et al. Effects of the CCR5-Delta32 mutation on antiviral treatment in chronic hepatitis C. J Hepatol 39 (2003) 245-252
35. Promrat K., McDermott D.H., Gonzalez C.M., Kleiner D.E., Koziol D.E., Lessie M., et al. Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C. Gastroenterology 124 (2003) 352-360
36. Goyal A., Kazim S.N., Sakhuja P., Malhotra V., Arora N., and Sarin S.K. Association of TNF-β polymorphism with disease severity among patients infected with Hepatitis C Virus. J Med Virol 72 (2004) 60-65
37. McGuire W., Hill A.H., Allsopp C.E., Greenwood B.M., and Kwiatkowski D. Variation in the TNF α promoter region associated with susceptibility to cerebral malaria. Nature 371 (1994) 508-510
38. Majetschak M., Flohe S., Obertacke U., Schroder J., Staubach K., Nast-Kolb D., et al. Relation of a TNF gene polymorphism to severe sepsis in trauma patients. Ann Surg 230 (1999) 207-214
39. Richardson M.M., Powell E.E., Barrie H.E., Clouston A.D., Purdie D.M., and Jonsson J.R. A combination of genetic polymorphisms increases the risk of progressive disease in chronic hepatitis C. J Med Genet 42 (2005) e45
40. Morrison N.A., Qi J.C., Tokita A., Kelly P.J., Crofts L., Nguyen T.V., et al. Prediction of bone density from vitamin D receptor alleles. Nature 367 (1994) 284-287